Poor Generic Drug Label Can Be Put On Novartis, Court Says
A California state appeals court ruled Wednesday that brand-name drug maker Novartis could be held liable for negligent misrepresentation and failure to warn of the alleged dangers of a generic version...To view the full article, register now.
Already a subscriber? Click here to view full article